Happy Thanksgiving!
All Texas Retina Associates offices will be closed Thursday, November 26, and Friday, November 27, for the Thanksgiving holiday. During this time of reflection and giving thanks, we want you to know how
read more
New Clinical Trials Enrolling in Plano
At Texas Retina Associates, we remain committed to examining new options that are ethical, based on a solid science platform and provide minimal risks to our patients. Our Plano research team is
read more
Ashkan M. Abbey, MD, Taught a Course at the American Academy of Ophthalmology 2020 Virtual Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, taught a course on “Secondary IOL Techniques for Retinal Specialists” at this year’s AAO 2020 virtual meeting held November 14-17, 2020. With more than 32,000
read more
Control Your Diabetes to Protect Your Vision
November is National Diabetes Month. Diabetes is a disease that occurs when your blood sugar, also known as blood glucose, is too high. It damages blood vessels all over the body, including
read more
Dr. Choi’s Research on Utilizing Artificial Intelligence to Aid in the Diagnosis of Plus Disease in Retinopathy of Prematurity Patients Published in Ophthalmology Retina
Texas Retina Associates’ Rene Y. Choi, MD, published an article titled “Variability in Plus Disease Identified Using a Deep Learning-Based Retinopathy of Prematurity Severity Scale” in the latest issue of Ophthalmology Retina,
read more
Dr. Abbey Highlights Five Noteworthy Presentations from the ASRS Annual Meeting in the Latest Issue of Retina Specialist
Texas Retina Associates’ Ashkan Abbey, MD, published an article in the current issue of Retina Specialist, highlighting the findings of five intriguing presentations from the recent 38th Annual Scientific Meeting of the
read more
Dr. Abbey’s Research Published in Retina, the Journal of Retinal and Vitreous Diseases
Texas Retina Associates’ Ashkan Abbey, MD, has published research in the medical journal Retina. Titled “Refractive Outcomes After Sutureless Intrascleral Fixation of Intraocular Lens with Pars Plana Vitrectomy,” the results of his work
read more
Texas Retina Associates Participating in New Phase II Clinical Trial for Choroidal Melanoma
Texas Retina Associates is pleased to announce its participation in a groundbreaking new Phase II clinical trial for the treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences, we are investigating
read more
Offices Closed for Labor Day
All Texas Retina Associates offices will be closed on Monday, September 7, 2020, in observance of Labor Day. We wish everyone a safe and happy holiday weekend!
read more
New Clinical Trials Offer Patients Access to Promising New Retina Treatments
At Texas Retina Associates, we remain committed to safely providing our patients with compassionate and personalized retina care, including access to breakthrough, sight-saving treatments through clinical trials. In fact, our physicians have
read more